-
1
-
-
20344399217
-
-
American Academy of Sleep Medicine, Chicago, IL, P. Hauri (Ed.), American Academy of Sleep Medicine
-
American Academy of Sleep Medicine The international classification of sleep disorders - revised 2005, American Academy of Sleep Medicine, Chicago, IL. P. Hauri (Ed.).
-
(2005)
The international classification of sleep disorders - revised
-
-
-
2
-
-
67049119032
-
Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients
-
Vernet C., Arnulf I. Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients. Sleep 2009, 32:752-759.
-
(2009)
Sleep
, vol.32
, pp. 752-759
-
-
Vernet, C.1
Arnulf, I.2
-
3
-
-
77958617039
-
Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness
-
Vernet C., Leu-Semenescu S., Buzare M., et al. Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness. J Sleep Res 2010, 19:525-534.
-
(2010)
J Sleep Res
, vol.19
, pp. 525-534
-
-
Vernet, C.1
Leu-Semenescu, S.2
Buzare, M.3
-
5
-
-
62549089695
-
CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome
-
Kanbayashi T., Kodama T., Kondo H., et al. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep 2009, 32:181-187.
-
(2009)
Sleep
, vol.32
, pp. 181-187
-
-
Kanbayashi, T.1
Kodama, T.2
Kondo, H.3
-
6
-
-
77958579815
-
Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin
-
Bassetti C.L., Baumann C.R., Dauvilliers Y., et al. Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin. J Sleep Res 2010, 19:620-623.
-
(2010)
J Sleep Res
, vol.19
, pp. 620-623
-
-
Bassetti, C.L.1
Baumann, C.R.2
Dauvilliers, Y.3
-
7
-
-
84867045078
-
Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions
-
Dauvilliers Y., Delallee N., Jaussent I., et al. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions. Sleep 2012, 35:1359-1366.
-
(2012)
Sleep
, vol.35
, pp. 1359-1366
-
-
Dauvilliers, Y.1
Delallee, N.2
Jaussent, I.3
-
8
-
-
36849065939
-
Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin
-
Morgenthaler T., Kapur V., Brown T., et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep 2007, 30:1705-1711.
-
(2007)
Sleep
, vol.30
, pp. 1705-1711
-
-
Morgenthaler, T.1
Kapur, V.2
Brown, T.3
-
9
-
-
79957997424
-
Benefit and risk of modafinil in idiopathic hypersomnia versus. narcolepsy with cataplexy
-
Lavault S., Dauvilliers Y., Drouot X., et al. Benefit and risk of modafinil in idiopathic hypersomnia versus. narcolepsy with cataplexy. Sleep Med 2011, 12:550-556.
-
(2011)
Sleep Med
, vol.12
, pp. 550-556
-
-
Lavault, S.1
Dauvilliers, Y.2
Drouot, X.3
-
10
-
-
75749085837
-
Idiopathic hypersomnia: clinical features and response to treatment
-
Ali M., Auger R., Slocumb N., et al. Idiopathic hypersomnia: clinical features and response to treatment. J Clin Sleep Med 2009, 5:562-568.
-
(2009)
J Clin Sleep Med
, vol.5
, pp. 562-568
-
-
Ali, M.1
Auger, R.2
Slocumb, N.3
-
11
-
-
35148900346
-
Idiopathic hypersomnia: a study of 77 cases
-
Anderson K., Pilsworth S., Sharples L., et al. Idiopathic hypersomnia: a study of 77 cases. Sleep 2007, 30:1274-1281.
-
(2007)
Sleep
, vol.30
, pp. 1274-1281
-
-
Anderson, K.1
Pilsworth, S.2
Sharples, L.3
-
12
-
-
84856490407
-
Quality of life in patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time: comparison between patients on psychostimulants, drug-naive patients and the general Japanese population
-
Ozaki A., Inoue Y., Hayashida K., et al. Quality of life in patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time: comparison between patients on psychostimulants, drug-naive patients and the general Japanese population. Sleep Med 2012, 13:200-206.
-
(2012)
Sleep Med
, vol.13
, pp. 200-206
-
-
Ozaki, A.1
Inoue, Y.2
Hayashida, K.3
-
13
-
-
84872339899
-
Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review
-
Nittur N., Konofal E., Dauvilliers Y., et al. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review. Sleep Med 2013, 14:30-36.
-
(2013)
Sleep Med
, vol.14
, pp. 30-36
-
-
Nittur, N.1
Konofal, E.2
Dauvilliers, Y.3
-
14
-
-
40849137722
-
An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients
-
Lin J.S., Dauvilliers Y., Arnulf I., et al. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol Dis 2008, 30:74-83.
-
(2008)
Neurobiol Dis
, vol.30
, pp. 74-83
-
-
Lin, J.S.1
Dauvilliers, Y.2
Arnulf, I.3
-
15
-
-
84885378478
-
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
-
Dauvilliers Y., Bassetti C., Lammers G.J., et al. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol 2013, 12:1068-1075.
-
(2013)
Lancet Neurol
, vol.12
, pp. 1068-1075
-
-
Dauvilliers, Y.1
Bassetti, C.2
Lammers, G.J.3
-
16
-
-
84862791691
-
Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness
-
Inocente C., Arnulf I., Bastuji H., et al. Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness. Clin Neuropharmacol 2012, 35:55-60.
-
(2012)
Clin Neuropharmacol
, vol.35
, pp. 55-60
-
-
Inocente, C.1
Arnulf, I.2
Bastuji, H.3
-
18
-
-
79958026433
-
The histamine H3 receptor: from discovery to clinical trials with pitolisant
-
Schwartz J.C. The histamine H3 receptor: from discovery to clinical trials with pitolisant. Br J Pharmacol 2011, 163:713-721.
-
(2011)
Br J Pharmacol
, vol.163
, pp. 713-721
-
-
Schwartz, J.C.1
-
19
-
-
84883768395
-
Alerting and psychomotor performance effects of the histamine H3 inverse agonist MK-0249 in obstructive sleep apnea patients on CPAP with excessive daytime sleepiness: a randomized adaptive crossover study
-
Herring W., Liu K., Hutzelmann J., et al. Alerting and psychomotor performance effects of the histamine H3 inverse agonist MK-0249 in obstructive sleep apnea patients on CPAP with excessive daytime sleepiness: a randomized adaptive crossover study. Sleep Med 2013, 14:955-963.
-
(2013)
Sleep Med
, vol.14
, pp. 955-963
-
-
Herring, W.1
Liu, K.2
Hutzelmann, J.3
-
20
-
-
34548324621
-
Influence of (R)-alpha-methylhistamine on the histamine H3 receptor in the rat gastrointestinal tract
-
Chazot P., Shenton F., Schunack W., et al. Influence of (R)-alpha-methylhistamine on the histamine H3 receptor in the rat gastrointestinal tract. Inflamm Res 2007, 56(Suppl 1):S19-S20.
-
(2007)
Inflamm Res
, vol.56
, Issue.SUPPL. 1
-
-
Chazot, P.1
Shenton, F.2
Schunack, W.3
-
21
-
-
33645130900
-
Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract
-
Sander L.E., Lorentz A., Sellge G., et al. Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract. Gut 2006, 55:498-504.
-
(2006)
Gut
, vol.55
, pp. 498-504
-
-
Sander, L.E.1
Lorentz, A.2
Sellge, G.3
-
23
-
-
84856716148
-
Increasing histamine neurotransmission in Gilles de la Tourette syndrome
-
Hartmann A., Worbe Y., Arnulf I. Increasing histamine neurotransmission in Gilles de la Tourette syndrome. J Neurol 2011, 259:375-376.
-
(2011)
J Neurol
, vol.259
, pp. 375-376
-
-
Hartmann, A.1
Worbe, Y.2
Arnulf, I.3
-
24
-
-
84877837311
-
Preclinical evaluation of the abuse potential of pitolisant, a histamine H3 receptor inverse agonist/antagonist compared with modafinil
-
Uguen M., Perrin D., Belliard S., et al. Preclinical evaluation of the abuse potential of pitolisant, a histamine H3 receptor inverse agonist/antagonist compared with modafinil. Br J Pharmacol 2013, 169:632-644.
-
(2013)
Br J Pharmacol
, vol.169
, pp. 632-644
-
-
Uguen, M.1
Perrin, D.2
Belliard, S.3
|